Next |
home / stock / sprb / sprb message board
Subject | By | Source | When |
---|---|---|---|
$SPRB MomentumIts gaining last trade up | pzottkpz | investorshub | 05/14/2023 3:01:39 AM |
$SPRB MomentumIts trading | TheFinalCD | investorshub | 05/14/2023 12:32:56 AM |
$SPRB Anyone hear anything lately? Want to see this one go | MiamiGent | investorshub | 05/11/2023 8:49:01 AM |
$SPRB Do we have a winner?Turn around time? | MiamiGent | investorshub | 05/10/2023 11:39:50 PM |
news out | pzottkpz | investorshub | 05/07/2023 8:29:52 PM |
$SPRB should we be shorting? | pzottkpz | investorshub | 05/06/2023 9:14:43 PM |
The trading last up | pzottkpz | investorshub | 05/06/2023 7:13:44 AM |
$SPRB When is this gonna take off? | MiamiGent | investorshub | 05/05/2023 7:10:46 PM |
news out | TheFinalCD | investorshub | 05/04/2023 1:10:01 AM |
$SPRB Price now up | pzottkpz | investorshub | 05/03/2023 6:29:31 AM |
and the shorts continue | pzottkpz | investorshub | 05/02/2023 10:28:41 PM |
$SPRB What do you make of this? | pzottkpz | investorshub | 05/02/2023 1:48:23 PM |
here we go bulls news is here | pzottkpz | investorshub | 05/01/2023 9:27:23 AM |
$SPRB Price trading last trade up | pzottkpz | investorshub | 04/28/2023 8:02:33 PM |
$SPRB Price now | subslover | investorshub | 04/25/2023 11:16:33 PM |
are we finally gonna see some action | pzottkpz | investorshub | 04/21/2023 1:46:08 AM |
what does this mean? | surf1944 | investorshub | 04/20/2023 8:52:40 AM |
$SPRB The trading up | MiamiGent | investorshub | 04/18/2023 12:26:09 PM |
MomentumIts gaining last trade up | MiamiGent | investorshub | 04/17/2023 8:41:27 PM |
The gaining | pzottkpz | investorshub | 04/16/2023 7:03:24 PM |
News, Short Squeeze, Breakout and More Instantly...
Spruce Biosciences Inc. Company Name:
SPRB Stock Symbol:
NASDAQ Market:
Spruce Biosciences Inc. Website:
Spruce Biosciences, Inc . (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine and neurological disorders with significant unmet medical need, announced that the San Francisco Business Times and the Silicon Valley Busines...
Pairs Spruce’s Investigational Product Candidate, Tildacerfont, with HMNC’s Companion Diagnostic, the Proprietary Cortibon Genetic Selection Tool, to Treat MDD Patients Responsive to CRF 1 Receptor Antagonism Provides Spruce with Option to In-License Exclusive Worldwide ...
Significant Reduction in Dehydroepiandrosterone Sulfate ( DHEAS) Versus Placebo Observed in Women with Elevated DHEAS Levels at Baseline Increase in Serum Sex Hormone Binding Globulin (SHBG) Versus Placebo Observed Tildacerfont was Well-Tolerated with No Safety Signals ...